Cargando…

Pan-cancer analysis of fear of cancer recurrence among cancer survivors

BACKGROUND: Fear of cancer recurrence (FCR) is a phenomenon estimated to affect a large portion of cancer survivors. This study sought to determine whether patients from a National Cancer Institute-designated institution had their clinical needs met relating to FCR. PATIENTS AND METHODS: Patients re...

Descripción completa

Detalles Bibliográficos
Autores principales: Adashek, J.J., Jordan, A., Redwine, L.S., Tyson, D. Martinez, Thompson, Z., Pabbathi, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463169/
https://www.ncbi.nlm.nih.gov/pubmed/35780591
http://dx.doi.org/10.1016/j.esmoop.2022.100528
_version_ 1784787339328880640
author Adashek, J.J.
Jordan, A.
Redwine, L.S.
Tyson, D. Martinez
Thompson, Z.
Pabbathi, S.
author_facet Adashek, J.J.
Jordan, A.
Redwine, L.S.
Tyson, D. Martinez
Thompson, Z.
Pabbathi, S.
author_sort Adashek, J.J.
collection PubMed
description BACKGROUND: Fear of cancer recurrence (FCR) is a phenomenon estimated to affect a large portion of cancer survivors. This study sought to determine whether patients from a National Cancer Institute-designated institution had their clinical needs met relating to FCR. PATIENTS AND METHODS: Patients referred to the survivorship clinic completed The Clinical Needs Assessment Tool for Cancer Survivors (CNAT-CS). Correlations between responses were calculated and univariable and multivariable logistic regression was used to identify predictors of met or unmet needs related to FCR. RESULTS: Of 647 patients, 241 (37.2%) reported they did not have clinical needs related to FCR and 386 (59.7%) reported they had clinical needs related to FCR but that the needs had been met. Only 20 (3.09%) reported that clinical needs relating to FCR were unmet. According to univariate logistic regression, sex had no impact on FCR (P = 0.8427), nor did years since diagnosis (P = 0.1014). Results of multivariable regression indicate that the odds ratio of reported FCR as an unmet need (versus not a need) is 0.939; the odds decreased by 6% (P = 0.0023) for every year increase in age. For each unit increase in distress score, the odds of reporting FCR as an unmet need increased by 32% (P = 0.0007). CONCLUSIONS: This study is unique in not only examining the presence of FCR but also whether patients reported that their needs were met for FCR. The study found that most patients had clinical needs for FCR, but the needs were met at the time of the survey. Patients who report higher distress scores are more likely to report FCR as an unmet need. Therefore, cancer survivors reporting high distress scores in clinic visits should be evaluated for FCR.
format Online
Article
Text
id pubmed-9463169
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94631692022-09-11 Pan-cancer analysis of fear of cancer recurrence among cancer survivors Adashek, J.J. Jordan, A. Redwine, L.S. Tyson, D. Martinez Thompson, Z. Pabbathi, S. ESMO Open Original Research BACKGROUND: Fear of cancer recurrence (FCR) is a phenomenon estimated to affect a large portion of cancer survivors. This study sought to determine whether patients from a National Cancer Institute-designated institution had their clinical needs met relating to FCR. PATIENTS AND METHODS: Patients referred to the survivorship clinic completed The Clinical Needs Assessment Tool for Cancer Survivors (CNAT-CS). Correlations between responses were calculated and univariable and multivariable logistic regression was used to identify predictors of met or unmet needs related to FCR. RESULTS: Of 647 patients, 241 (37.2%) reported they did not have clinical needs related to FCR and 386 (59.7%) reported they had clinical needs related to FCR but that the needs had been met. Only 20 (3.09%) reported that clinical needs relating to FCR were unmet. According to univariate logistic regression, sex had no impact on FCR (P = 0.8427), nor did years since diagnosis (P = 0.1014). Results of multivariable regression indicate that the odds ratio of reported FCR as an unmet need (versus not a need) is 0.939; the odds decreased by 6% (P = 0.0023) for every year increase in age. For each unit increase in distress score, the odds of reporting FCR as an unmet need increased by 32% (P = 0.0007). CONCLUSIONS: This study is unique in not only examining the presence of FCR but also whether patients reported that their needs were met for FCR. The study found that most patients had clinical needs for FCR, but the needs were met at the time of the survey. Patients who report higher distress scores are more likely to report FCR as an unmet need. Therefore, cancer survivors reporting high distress scores in clinic visits should be evaluated for FCR. Elsevier 2022-07-01 /pmc/articles/PMC9463169/ /pubmed/35780591 http://dx.doi.org/10.1016/j.esmoop.2022.100528 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Adashek, J.J.
Jordan, A.
Redwine, L.S.
Tyson, D. Martinez
Thompson, Z.
Pabbathi, S.
Pan-cancer analysis of fear of cancer recurrence among cancer survivors
title Pan-cancer analysis of fear of cancer recurrence among cancer survivors
title_full Pan-cancer analysis of fear of cancer recurrence among cancer survivors
title_fullStr Pan-cancer analysis of fear of cancer recurrence among cancer survivors
title_full_unstemmed Pan-cancer analysis of fear of cancer recurrence among cancer survivors
title_short Pan-cancer analysis of fear of cancer recurrence among cancer survivors
title_sort pan-cancer analysis of fear of cancer recurrence among cancer survivors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463169/
https://www.ncbi.nlm.nih.gov/pubmed/35780591
http://dx.doi.org/10.1016/j.esmoop.2022.100528
work_keys_str_mv AT adashekjj pancanceranalysisoffearofcancerrecurrenceamongcancersurvivors
AT jordana pancanceranalysisoffearofcancerrecurrenceamongcancersurvivors
AT redwinels pancanceranalysisoffearofcancerrecurrenceamongcancersurvivors
AT tysondmartinez pancanceranalysisoffearofcancerrecurrenceamongcancersurvivors
AT thompsonz pancanceranalysisoffearofcancerrecurrenceamongcancersurvivors
AT pabbathis pancanceranalysisoffearofcancerrecurrenceamongcancersurvivors